Guest guest Posted September 28, 2008 Report Share Posted September 28, 2008 Hi Karl. I know that you are aware of the 2 trials that I will mention; but other people may not be. Genitope offered a vaccine trial for untreated CLLers, which it aborted after a year or so. The last I heard, the company had reduced to a 'skeleton crew,' perhaps in a couple of senses. Several participants in that trial joined a Group for vaccines and shared their results. It might still be hoped that their vaccines have slowed the progression of their CLL; but no remissions have been reported. In less than 3 weeks I will be beginning my trial of "revlimid first line." A description of that trial is here: http://clinicaltrials.gov/ct2/show/NCT00535873 wayne (trying again....what happened to what I typed before?) Hi Karl.You wrote: ...........we may be missing opportunities to test some agents when they will do the most good. Such as immunotherapy on the previously untreated, who may have better immune competence and ability to benefit ... such as revlimid first line? Perhaps the NCI and cooperative groups will sponsor such trials. Query of clinicaltrils. gov (in untreated CLL):http://tinyurl. com/3otp8gAll the best,Karl Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.